A transgenic model to study Bif-1 mediated neuroprotection in injury and disease

研究 Bif-1 介导的损伤和疾病神经保护的转基因模型

基本信息

  • 批准号:
    8815342
  • 负责人:
  • 金额:
    $ 23.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-03-15 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Accumulating evidence demonstrates that mitochondrial dysfunction is both associated with and causally related to neurodegeneration observed in response to injury and diseases affecting the brain. While disturbances in energy metabolism and ATP production have received significant attention, abnormalities are also being found in the regulation of mitochondrial dynamics which involves the processes of fusion and fission (fragmentation) affecting the shape and size of mitochondria. Importantly, mitochondrial fusion and fission are directly involved in ensuring their proper distribution, transport, and turnover. Considering how vital it is for neurons to have healthy mitochondria positioned at sites of energy demand, it is not difficult to imagine that genetic or epigenetic modifications that impair the regulation of mitochondrial fission and fusion could adversely affect neuronal connectivity, function and viability. We recently determined that neurons express two alternatively spliced forms of a mitochondrial fission regulating protein, Bif-1 (Bif-1b/c). Our preliminary data demonstrates that Bif-1b/c is lost in neurons in the penumbra (cerebral cortex) of mice subjected to middle cerebral artery occlusion (MCAO, stroke model). Importantly, the Bif-1-null condition enhanced neuronal cell death caused by MCAO, and DNA damage and Abeta cytotoxicity in culture. Conversely, Bif-1c overexpression confers significant protection against Abeta-mediated toxicity indicating that Bif-1 is required for normal neuronal function. The Bif-1b/c protein is significantly reduced in the parietal cortex (affected area) and in synaptosomes of sporadic Alzheimer's disease (AD) patients compared to aged matched non-AD patients. These changes in Bif-1b/c are also observed in the APPswe/PS1dE9 mouse AD model and in primary cortical neurons following addition of the toxic Abeta peptide. Moreover, in preliminary studies, Bif-1-null mice displayed significant cognitive impairment at one year of age and knockout of the Bif-1 homologue (endoB) in drosophila enhanced the toxicity of the toxic Abeta42 peptide based on an eye phenotype, but had no effect on flies expressing the non-toxic Abeta40 peptide. These findings demonstrate a potential neuroprotective function of Bif-1 and suggest that mitochondrial dysfunction associated with ischemic damage and AD may be due to reduced expression of Bif-1b/c. We propose to test the hypothesis that restoration of Bif-1c expression in neurons in an inducible transgenic mouse promotes neuronal survival, retention of mitochondrial integrity and enhances cognitive function in response to stroke and in a mouse model of AD. These studies will determine if Bif-1c has therapeutic actions for reducing injury and disease-induced damage.
描述(由申请人提供):越来越多的证据表明,线粒体功能障碍与在对影响大脑的损伤和疾病做出反应时观察到的神经变性相关且存在因果关系。虽然能量代谢和ATP产生的干扰受到了极大的关注,但在线粒体动力学的调节中也发现了异常,其中涉及影响线粒体形状和大小的融合和分裂(碎片化)过程。重要的是,线粒体融合和分裂直接参与确保它们的适当分布,运输和周转。考虑到神经元将健康的线粒体定位在能量需求部位是多么重要,不难想象,损害线粒体分裂和融合调节的遗传或表观遗传修饰可能会对神经元产生不利影响。 神经元连接、功能和活力。我们最近确定,神经元表达线粒体分裂调节蛋白Bif-1(Bif-1b/c)的两种选择性剪接形式。我们的初步数据表明,Bif-1b/c在大脑中动脉闭塞(MCAO,中风模型)小鼠的半影区(大脑皮层)的神经元中丢失。重要的是,Bif-1-null条件增强了由MCAO引起的神经元细胞死亡,以及培养物中的DNA损伤和Abeta细胞毒性。相反,Bif-1c过表达赋予针对Abeta介导的毒性的显著保护,表明Bif-1是正常神经元功能所需的。与年龄匹配的非AD患者相比,散发性阿尔茨海默病(AD)患者的顶叶皮质(受累区域)和突触体中的Bif-1b/c蛋白显著减少。在APPswe/PS1 dE 9小鼠AD模型和加入毒性Abeta肽后的原代皮层神经元中也观察到Bif-1b/c的这些变化。此外,在初步研究中,Bif-1-null小鼠在一岁时表现出显著的认知障碍,并且敲除果蝇中的Bif-1同源物(endoB)增强了基于眼睛表型的毒性Abeta 42肽的毒性,但对表达无毒Abeta 40肽的果蝇没有影响。这些发现表明Bif-1具有潜在的神经保护功能,并表明与缺血性损伤和AD相关的线粒体功能障碍可能是由于Bif-1b/c表达减少所致。我们建议测试的假设,即恢复诱导型转基因小鼠的神经元中的Bif-1c表达促进神经元的存活,线粒体的完整性的保留,并增强认知功能,在中风和AD的小鼠模型。这些研究将确定Bif-1c是否具有减少损伤和疾病引起的损伤的治疗作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD S MORRISON其他文献

RICHARD S MORRISON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD S MORRISON', 18)}}的其他基金

Functional characterization of the Bax-interacting factor-1 interactome in neurons
神经元中 Bax 相互作用因子 1 相互作用组的功能表征
  • 批准号:
    9475333
  • 财政年份:
    2017
  • 资助金额:
    $ 23.18万
  • 项目类别:
Functional characterization of the Bax-interacting factor-1 interactome in neurons
神经元中 Bax 相互作用因子 1 相互作用组的功能表征
  • 批准号:
    9387154
  • 财政年份:
    2017
  • 资助金额:
    $ 23.18万
  • 项目类别:
A transgenic model to study Bif-1 mediated neuroprotection in injury and disease
研究 Bif-1 介导的损伤和疾病神经保护的转基因模型
  • 批准号:
    8694930
  • 财政年份:
    2014
  • 资助金额:
    $ 23.18万
  • 项目类别:
Histone deacetylases - therapeutic targets for functional restoration after strok
组蛋白脱乙酰酶 - 中风后功能恢复的治疗靶点
  • 批准号:
    8243635
  • 财政年份:
    2010
  • 资助金额:
    $ 23.18万
  • 项目类别:
Histone deacetylases - therapeutic targets for functional restoration after strok
组蛋白脱乙酰酶 - 中风后功能恢复的治疗靶点
  • 批准号:
    8048964
  • 财政年份:
    2010
  • 资助金额:
    $ 23.18万
  • 项目类别:
Histone deacetylases - therapeutic targets for functional restoration after strok
组蛋白脱乙酰酶 - 中风后功能恢复的治疗靶点
  • 批准号:
    8440328
  • 财政年份:
    2010
  • 资助金额:
    $ 23.18万
  • 项目类别:
Histone deacetylases - therapeutic targets for functional restoration after strok
组蛋白脱乙酰酶 - 中风后功能恢复的治疗靶点
  • 批准号:
    8634140
  • 财政年份:
    2010
  • 资助金额:
    $ 23.18万
  • 项目类别:
Histone deacetylases - therapeutic targets for functional restoration after strok
组蛋白脱乙酰酶 - 中风后功能恢复的治疗靶点
  • 批准号:
    7899421
  • 财政年份:
    2010
  • 资助金额:
    $ 23.18万
  • 项目类别:
Mechanisms of Neuroprotection by Histone Deacetylase Inhibition
组蛋白脱乙酰酶抑制的神经保护机制
  • 批准号:
    7461900
  • 财政年份:
    2008
  • 资助金额:
    $ 23.18万
  • 项目类别:
NINDS INSTITUTIONAL CENTER CORE GRANTS - Neuroproteomics P30
NINDS 机构中心核心资助 - 神经蛋白质组学 P30
  • 批准号:
    8116685
  • 财政年份:
    2008
  • 资助金额:
    $ 23.18万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了